Name | Type | Posted | Actions |
|---|---|---|---|
Section D - Solicitation 1.21.2021.doc | DOC | Jan 21, 2021 |
Vaccines for Children 2021
Contact and place of performance
Christina McMichael
Not specified
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following pediatric vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration: ITEM SUPPLIES / SERVICES...
View moreThe Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD) requires one or more indefinite quantity, indefinite delivery contracts for the purchase of various pediatric vaccines. These vaccines must be manufactured under current establishment and product licenses issued by the U.S. Food and Drug Administration. Procured items support pediatric immunization programs under Section 317(j) of the Public Health Service Act and the Vaccine for Children (VFC) program. This acquisition is categorized under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and PSC 6505 for Drugs and Biologicals.
The scope of the requirement covers 20 specific vaccine types, including DTaP, Hepatitis A and B, Hib, Human Papillomavirus, MMR, Meningococcal, Pneumococcal, Rotavirus, Tdap, and Varicella. Each vaccine item carries a minimum shelf life requirement of 12 months and specified federal excise taxes ranging from $0.75 to $3.75 per dose. Estimated quantities vary by item, with maximums reaching up to 13 million doses for certain formulations. Vaccines will be shipped F.O.B. Destination to all 50 states and U.S. Territories.
Solicitation 75D301-21-R-71773 is a combined synopsis/solicitation conducted in accordance with FAR Part 12 for the acquisition of commercial items. The performance period is scheduled to run from April 1, 2021, through March 31, 2022. Responses are due by February 4, 2021, and all inquiries must be submitted in writing to the point of contact, Christina McMichael. One attachment, titled Section D - Solicitation 1.21.2021.doc, was provided at the time of publication.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.